# Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial

> **NCT01492725** · PHASE2 · TERMINATED · sponsor: **Neuroscience Trials Australia** · enrollment: 70 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DEVICE:** Intra-arterial Clot Retrieval with Solitaire device
- **GENETIC:** intravenous tissue plasminogen activator (tPA)

## Key facts

- **NCT ID:** NCT01492725
- **Lead sponsor:** Neuroscience Trials Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** On DSMB advice, trial recruitment has been halted for efficacy. F/U continues
- **Last updated:** 2015-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492725, "Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01492725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*